Download PDF
Drug Res (Stuttg) 2016; 66(S 01): S10
DOI: 10.1055/s-0042-114456
Symposium der Paul-Martini-Stiftung
Georg Thieme Verlag KG Stuttgart · New York

Diabetes Type 2 Treatments

M. Tschöp
Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt und Lehrstuhl für Stoffwechselerkrankungen an der Technischen Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
02 November 2016 (online)

Also available at
   Permissions and Reprints

After decades of research unraveling complex metabolic control networks, medicines capable of a safe reversal of type 2 diabetes are still not available. Historically, complex diseases have repeatedly proven to be defiant to the best mono-therapeutic approaches. Several examples of combination therapies have largely overcome such challenges, notably for the treatment of severe hypertension and tuberculosis.